CLEVELAND, OHIO, USA (November 2017) — John Gannon, President and CEO of Blue Spark Technologies, will be sharing a wealth of insight during MEDICA’s “Patient Centered IoT Solutions” session on November 14. His session, titled, “Connected Healthcare: Wireless, Continuous Temperature Monitoring that Provides Earlier Detection of Fever for Inpatient and Remote Outpatient Monitoring,” will address the benefits of continuously monitoring patient body temperatures for a variety of conditions and cases.
Most recently, Gannon’s company, which invented, patented and manufactured TempTraq®, the only wearable, Bluetooth® continuous temperature monitor, received promising clinical study results for its medical device. A University Hospitals Seidman Cancer Center (UH) study shows the wearable can detect a rise in body temperature up to 180 minutes earlier, in a majority of patient cases, than the current standard-of-care (SOC) method, allowing medical professionals the chance to intervene more quickly.
“This temperature monitoring patch has the potential to improve clinical outcomes for patients undergoing stem cell transplant and intensive chemotherapy for hematological malignancies by identifying neutropenic fever and beginning clinical interventions sooner,” said Dr. Ehsan Malek, MD, UH Seidman Cancer Center. “We are looking forward to the next step in our research—implementing this temperature patch in the outpatient stem cell transplant setting.”
Ad Statistics
Times Displayed: 172925
Times Visited: 3140 For those who need to move fast and expand clinical capabilities -- and would love new equipment -- the uCT 550 Advance offers a new fully configured 80-slice CT in up to 2 weeks with routine maintenance and parts and Software Upgrades for Life™ included.
Unlike other devices and methods that provide physicians with only one point of data and offer no continuous monitoring or alerts, this patented device is the ideal, non-invasive, solution for doctors and nurses who need a continuous, smarter way to track, log and respond to fevers quickly.
“It has been very exciting for our project team, the bedside nursing staff, and our patients to see this device working in real time,” said Nina Dambrosio, MSN CNP, UH Seidman Cancer Center.
To study this continuous, real-time method of body temperature measurement, UH tested the feasibility of monitoring body temperature for patients specifically undergoing stem cell transplant or intensive chemotherapy for leukemia. The patches were applied every 24 hours on 10 neutropenic patients throughout their hospital stays. Body temperature was recorded remotely with TempTraq in 10-minute intervals totaling 14,342 temperature measurements, versus the current SOC of one measurement every four hours.
